Skip to content

Tipranavir receives European marketing approval

New boosted PIs should be used with T-20 for maximum impact, say new US guidelines

Safety review board gives go-ahead for studies into Pfizer's CCR5 inhibitor to continue as planned

GSK halts chemokine inhibitor trial due to safety fears

Panacos announces results of first agent in new drug class

Ranbaxy says seven ARV products are back on WHO list

Could valproic acid eradicate HIV from the body?

Gilead reports problems putting tenofovir, FTC and efavirenz into one pill

Tipranavir moves closer to approval in Europe